Abstract
In this study, we tried to explore the molecular mechanism that Corilagin protected against herpes simplex virus-1 encephalitis through inhibiting the TLR2 signaling pathways in vivo and in vitro. As a result, Corilagin significantly prevented increase in the levels of TLR2 and its downstream mediators following Malp2 or HSV-1 challenge. On the other hand, in spite of TLR2 knockdown, Corilagin could still significantly suppress the expression of P38 and NEMO, phosphor-P38, and nuclear factor kappa B. The mRNA and protein expression of TLR2 and its downstream mediators in the brain tissue were also significantly lowered in mice treated with Corilagin. In addition, Corilagin inhibited expression of tumor necrosis factor-α (TNF-α) and interleukin (IL)-6 protein. In conclusion, Corilagin shows the potential to protect against HSV-1-induced encephalitis, and the beneficial effects may be mediated by inhibiting TLR2 signaling pathways.
Similar content being viewed by others
Reference
James SH, Kimberlin DW, Whitley RJ (2009) Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antivir Res 83(3):207–213
Lundberg P, Ramakrishna C, Brown J, Tyszka JM, Hamamura M, Hinton DR, Kovats S, Nalcioglu O, Weinberg K, Openshaw H (2008) The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol 82(14):7078–7088
Conrady CD, Drevets DA, Carr DJ (2010) Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing? J Neuroimmunol 220(1):1–9
Guo Y-J, Zhao L, Li X-F, Mei Y-W, Zhang S-L, Tao J-Y, Zhou Y, Dong J-H (2010) Effect of Corilagin on anti-inflammation in HSV-1 encephalitis and HSV-1 infected microglias. Eur J Pharmacol 635(1):79–86
Olson JK, Miller SD (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173(6):3916–3924
Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34(5):637–650
Kumar H, Kawai T, Akira S (2011) Pathogen recognition by the innate immune system. Int Rev Immunol 30(1):16–34
Blasius AL, Beutler B (2010) Intracellular Toll-like receptors. Immunity 32(3):305–315
Kielian T (2006) Toll‐like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res 83(5):711–730
Morrison LA (2004) The toll of herpes simplex virus infection. Trends Microbiol 12(8):353–356
Shen Z-Q, Dong Z-J, Peng H, Liu J-K (2004) Modulation of PAI-1 and tPA activity and thrombolytic effects of Corilagin. Planta Med 69(12):1109–1112
DUAN W, YU Y, ZHANG L (2005) Antiatherogenic effects of Phyllanthus emblica associated with Corilagin and its analogue. Yakugaku Zasshi 125(7):587–591
Kinoshita S, Inoue Y, Nakama S, Ichiba T, Aniya Y (2007) Antioxidant and hepatoprotective actions of medicinal herb,< i > Terminalia catappa</i > L. from Okinawa Island and its tannin Corilagin. Phytomedicine 14(11):755–762
Jin F, Cheng D, Tao J-Y, Zhang S-L, Pang R, Guo Y-J, Ye P, Dong J-H, Zhao L (2013) Anti-inflammatory and anti-oxidative effects of Corilagin in a rat model of acute cholestasis. BMC Gastroenterol 13(1):79
Cheng J-T, Lin T-C, Hsu F-L (1995) Antihypertensive effect of Corilagin in the rat. Can J Physiol Pharmacol 73(10):1425–1429
Shiota S, Shimizu M, Ji S, Morita Y, Mizushima T, Tsuchiya T (2004) Mechanisms of action of Corilagin and tellimagrandin I that remarkably potentiate the activity of beta-lactams against methicillin-resistant Staphylococcus aureus. Microbiol Immunol 48(1):67
Jia L, Jin H, Zhou J, Chen L, Lu Y, Ming Y, Yu Y (2013) A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways. BMC Complement Alternat Med 13(1):33
Huang YF, Zhang SL, Jin F, Cheng D, Zhou YP, Li HR, Tang ZM, Xue J, Cai W, Dong JH, Zhao L (2013) Activity of Corilagin on post-parasiticide liver fibrosis in schistosomiasis animal model. Int J Immunopathol Pharmacol 26(1):85–92
OKABE S, SUGANUMA M, IMAYOSHI Y, TANIGUCHI S, YOSHIDA T, FUJIKI H (2001) New TNF-ALPHA. Releasing inhibitors, Geraniin and Corilagin, in leaves of Acer nikoense, Megusurino-ki. Biol Pharm Bull 24(10):1145–1148
Gambari R, Borgatti M, Lampronti I, Fabbri E, Brognara E, Bianchi N, Piccagli L, Yuen MC-W, Kan C-W, Hau DK-P (2012) Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells. Int Immunopharmacol
Zhao L, Zhang S-L, Tao J-Y, Pang R, Jin F, Guo Y-J, Dong J-H, Ye P, Zhao H-Y, Zheng G-H (2008) Preliminary exploration on anti-inflammatory mechanism of Corilagin (beta-1-O-galloyl-3,6-(R)-hexahydroxydiphenoyl-d-glucose) in Vitro. Int Immunopharmacol 8(7):1059–1064
Henn A, Lund S, Hedtjärn M, Schrattenholz A, Pörzgen P, Leist M (2008) The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. Altex 26(2):83–94
Okusawa T, Fujita M, J-i N, Into T, Yasuda M, Yoshimura A, Hara Y, Hasebe A, Golenbock DT, Morita M (2004) Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by Toll-like receptors 2 and 6. Infect Immun 72(3):1657–1665
Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3(6):1101–1108
Guo G-z, Geng Y-j, Huang D-n, Xue C-f, Zhang R-l (2010) Level of CYP4G19 expression is associated with pyrethroid resistance in Blattella germanica. J Parasitol Res 2010
Lokensgard JR, Hu S, Sheng W, Vanoijen M, Cox D, Cheeran MC, Peterson PK (2001) Robust expression of TNF a, IL-1 ß, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J Neurovirol 7(3):208–219
Marques CP, Hu S, Sheng W, Lokensgard JR (2006) Microglial cells initiate vigorous yet non-protective immune responses during HSV-1 brain infection. Virus Res 121(1):1–10
Stone MJ, Hawkins CP (2007) A medical overview of encephalitis. Neuropsychol Rehabil 17(4–5):429–449
Medzhitov R, Janeway CA (2002) Decoding the patterns of self and nonself by the innate immune system. Science 296(5566):298–300
Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11(5):373–384
van Lint AL, Murawski MR, Goodbody RE, Severa M, Fitzgerald KA, Finberg RW, Knipe DM, Kurt-Jones EA (2010) Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-κB signaling. J Virol 84(20):10802–10811
Schachtele SJ, Hu S, Little MR, Lokensgard JR (2010) Research herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2
Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW (2004) Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A 101(5):1315–1320
Sarangi PP, Kim B, Kurt-Jones E, Rouse BT (2007) Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J Virol 81(20):11128–11138
Cai M, Li M, Wang K, Wang S, Lu Q, Yan J, Mossman KL, Lin R, Zheng C (2013) The herpes Simplex virus 1-encoded envelope glycoprotein B activates NF-κB through the Toll-like receptor 2 and MyD88/TRAF6-dependent signaling pathway. PLoS One 8(1):e54586
Ono K, Han J (2000) The p38 signal transduction pathway activation and function. Cell Signal 12(1):1–13
Kwok S-K, Cho M-L, Her Y-M, Oh H-J, Park M-K, Lee S-Y, Woo YJ, Ju JH, Park K-S, Kim H-Y (2012) TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome. Arthritis Res Ther 14:R64
Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, Morr M, Mühlradt PF, Akira S (2000) Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2-and MyD88-dependent signaling pathway. J Immunol 164(2):554–557
Barrenschee M, Lex D, Uhlig S (2010) Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs. PLoS One 5(11):e13889
Deglon N, Aebischer P (2002) Lentiviruses as vectors for CNS diseases. In: Lentiviral vectors. Springer, pp 191–209
Horng T, Barton GM, Medzhitov R (2001) TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2(9):835–841
Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, Hoshino K, Takeuchi O, Kobayashi M, Fujita T (2002) Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420(6913):324–329
Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21(1):335–376
Verstak B, Nagpal K, Bottomley SP, Golenbock DT, Hertzog PJ, Mansell A (2009) MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2-and TLR4-mediated NF-κB proinflammatory responses. J Biol Chem 284(36):24192–24203
Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M (2004) Herpes simplex virus type 1 activates murine natural interferon-producing cells through Toll-like receptor 9. Blood 103(4):1433–1437
Tegethoff S, Behlke J, Scheidereit C (2003) Tetrameric oligomerization of IκB kinase γ (IKKγ) is obligatory for IKK complex activity and NF-κB activation. Mol Cell Biol 23(6):2029–2041
Israël A (2010) The IKK complex, a central regulator of NF-κB activation. Cold Spring Harbor perspectives in biology 2 (3)
Tripathi P, Aggarwal A (2006) NF-kB transcription factor: a key player in the generation of immune response. Curr Sci 90(4):519–531
Lee MS, Kim Y-J (2007) Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 76:447–480
Vasselon T, Hanlon WA, Wright SD, Detmers PA (2002) Toll-like receptor 2 (TLR2) mediates activation of stress-activated MAP kinase p38. J Leukoc Biol 71(3):503–510
Dong XR, Luo M, Fan L, Zhang T, Liu L, Dong JH, Wu G (2010) Corilagin inhibits the double strand break-triggered NF-kappaB pathway in irradiated microglial cells. Int J Mol Med 25(4):531–536
Li XF, Guo YJ, Zhang DM, Chen Z, Wei X, Li YH, Zhang SL, Tao JY, Dong JH, Mei YW, Li LL, Zhao L (2012) Protective activity of the ethanol extract of Cynanchum paniculatum (BUNGE) Kitagawa on treating herpes simplex encephalitis. Int J Immunopathol Pharmacol 25(1):259–266
Li XF, Guo YJ, Wang ML, Zhang DM, Li YH, Wang YF, Tao JY, Zhang SL, Dong JH, Li LL, Zhao L (2011) Inducing-apoptotic activity of the ethanol extract of Duchesnea indica Focke on treatment of herpes simplex encephalitis. Int J Immunopathol Pharmacol 24(3):631–638
Klein RS, Hirsch MS (2009) Herpes simplex virus type 1 encephalitis. UpToDate:1–17
Venturini E, Chiappini E, Fonda C, Galli L, de Martino M (2013) Herpes simplex encephalitis with occipital localization in an infant: a different route of entry in the brain system? Pediatr Neurol 48(6):463–465
Wilson SS, Fakioglu E, Herold BC (2009) Novel approaches in fighting herpes simplex virus infections. Expert Rev Anti-Infect Ther 7(5):559–568
Acknowledgments
This study is sponsored by China National Natural Science Fund No. 81100894, No. 81371840, and No. 30901248.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yuan-Jin Guo and Tao Luo contributed equally to this study.
Rights and permissions
About this article
Cite this article
Guo, YJ., Luo, T., Wu, F. et al. Corilagin Protects Against HSV1 Encephalitis Through Inhibiting the TLR2 Signaling Pathways In Vivo and In Vitro. Mol Neurobiol 52, 1547–1560 (2015). https://doi.org/10.1007/s12035-014-8947-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-014-8947-7